Arkolith/Insider Trading/AVTX/Form 4

Neil Garry Arthur

Chief Executive Officer, DirectorAvalo Therapeutics, Inc. (AVTX) · full profile →Form 4 · filed Mar 31, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2026Option exercise(M)65K——112K
Mar 28, 2026Tax withholding(F)22K$13.89$304K90K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2026Option exercise(M)65K—$065K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001586785-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML